加利福尼亚医用大麻患者中的污名化现象。
Stigma among California's Medical Marijuana Patients.
作者信息
Satterlund Travis D, Lee Juliet P, Moore Roland S
机构信息
a Research Analyst, Center for Program Design and Evaluation , Dartmouth College , Lebanon , NH.
出版信息
J Psychoactive Drugs. 2015 Jan-Mar;47(1):10-7. doi: 10.1080/02791072.2014.991858.
Abstract
The enactment of California's Proposition 215 stipulates that patients may use marijuana for medical reasons, provided that it is recommended by a physician. Yet, medical marijuana patients risk being stigmatized for this practice. This article examines the way in which medical marijuana patients perceive and process stigma, and how it affects their interactions and experiences with others. Eighteen semi-structured interviews of medical marijuana patients were carried out using a semi-structured interview guide. Most patients circumvented their own physicians in obtaining a recommendation to use medicinal marijuana, and also used a host of strategies in order to justify their medical marijuana use to family, friends, and colleagues in order to stave off potential stigma. The stigmatization of medical marijuana thus has a profound effect on how patients seek treatment, and whether they seek medical marijuana treatment at all.
摘要
加利福尼亚州第215号提案的颁布规定，患者出于医疗原因可以使用大麻，前提是有医生的推荐。然而，医用大麻患者却面临因这种行为而被污名化的风险。本文探讨了医用大麻患者感知和处理污名的方式，以及这种污名如何影响他们与他人的互动和经历。使用半结构化访谈指南对18名医用大麻患者进行了半结构化访谈。大多数患者在获取使用医用大麻的推荐时绕过了自己的医生，并且还采用了一系列策略，以便向家人、朋友和同事证明他们使用医用大麻的合理性，以避免潜在的污名。因此，医用大麻的污名化对患者寻求治疗的方式以及他们是否寻求医用大麻治疗有着深远的影响。
相似文献
1
Stigma among California's Medical Marijuana Patients.加利福尼亚医用大麻患者中的污名化现象。
J Psychoactive Drugs. 2015 Jan-Mar;47(1):10-7. doi: 10.1080/02791072.2014.991858.
2
Marijuana as a Substitute for Prescription Medications: A Qualitative Study.大麻作为处方药物替代品：一项定性研究。
Subst Use Misuse. 2019;54(11):1894-1902. doi: 10.1080/10826084.2019.1618336. Epub 2019 Jun 10.
3
Perceived support for medical cannabis use among approved medical cannabis users in Canada.加拿大已批准的医用大麻使用者对医用大麻使用的感知支持度。
Drug Alcohol Rev. 2018 Jul;37(5):627-636. doi: 10.1111/dar.12823. Epub 2018 Jun 5.
4
The Experiences of Medical Marijuana Patients: A Scoping Review of the Qualitative Literature.医用大麻患者的经历：定性文献的范围综述
J Neurosci Nurs. 2017 Jun;49(3):185-190. doi: 10.1097/JNN.0000000000000283.
5
An Ethical Framework to Manage Patient Requests for Medical Marijuana.管理患者对医用大麻需求的伦理框架。
J Am Board Fam Med. 2020 Jan-Feb;33(1):147-151. doi: 10.3122/jabfm.2020.01.190216.
6
Feeling labeled, judged, lectured, and rejected by family and friends over depression: cautionary results for primary care clinicians from a multi-centered, qualitative study.因抑郁被家人和朋友贴上标签、评判、说教和拒绝：一项多中心定性研究对初级保健临床医生的警示结果。
BMC Fam Pract. 2012 Jun 29;13:64. doi: 10.1186/1471-2296-13-64.
7
Clinicians Support Medical Marijuana Use in Children With Cancer, but Lack Knowledge.临床医生支持癌症患儿使用医用大麻，但缺乏相关知识。
JAMA. 2018 Mar 6;319(9):852-853. doi: 10.1001/jama.2018.0089.
8
Medical Board Expectations for Physicians Recommending Marijuana.医学委员会对推荐大麻的医生的期望。
JAMA. 2016 Aug 9;316(6):577-8. doi: 10.1001/jama.2016.7741.
9
Health conditions and motivations for marijuana use among young adult medical marijuana patients and non-patient marijuana users.年轻成年医用大麻患者和非医用大麻使用者的健康状况和使用大麻的动机。
Drug Alcohol Rev. 2018 Feb;37(2):237-246. doi: 10.1111/dar.12534. Epub 2017 Apr 23.
10
Marijuana and Listing for Heart Transplant: A Survey of Transplant Providers.大麻与心脏移植名单：移植提供者调查
Circ Heart Fail. 2016 Jul;9(7). doi: 10.1161/CIRCHEARTFAILURE.115.002851.
引用本文的文献
1
Patterns of Use and Patient-Reported Effects of Cannabinoids in People With PD: A Nationwide Survey.帕金森病患者使用大麻素的模式及患者报告的效果：一项全国性调查。
Parkinsons Dis. 2025 May 28;2025:2979089. doi: 10.1155/padi/2979089. eCollection 2025.
2
'In the weeds': navigating the complex concerns, challenges and choices associated with medicinal cannabis consumption for endometriosis.“深陷困境”：应对与子宫内膜异位症患者使用药用大麻相关的复杂问题、挑战及选择
Reprod Fertil. 2025 Jun 12;6(2). doi: 10.1530/RAF-24-0098. Print 2025 Apr 1.
3
Exploring cannabis consumption stigma in Canada with consideration of age and gender differences.探讨加拿大对大麻消费的污名化现象，并考虑年龄和性别差异。
Addict Behav Rep. 2025 Apr 13;21:100608. doi: 10.1016/j.abrep.2025.100608. eCollection 2025 Jun.
4
Detecting and understanding potential stigma among medical cannabis users in Germany.在德国检测并了解医用大麻使用者中潜在的污名化现象。
BMC Public Health. 2025 Mar 5;25(1):874. doi: 10.1186/s12889-025-22084-w.
5
Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson's disease: A French survey.帕金森病患者对大麻和大麻二酚治疗用途的接受度及态度：一项法国调查。
Clin Park Relat Disord. 2024 Nov 20;11:100286. doi: 10.1016/j.prdoa.2024.100286. eCollection 2024.
6
Discussions of Cannabis Over Patient Portal Secure Messaging: Content Analysis.通过患者门户安全消息功能对大麻相关讨论的内容分析
J Med Internet Res. 2024 Dec 12;26:e63311. doi: 10.2196/63311.
7
Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder.阿片类药物使用障碍治疗人群中对大麻二酚的使用和认知。
Harm Reduct J. 2024 Jul 17;21(1):135. doi: 10.1186/s12954-024-01051-5.
8
Understanding the epidemiology and perceived efficacy of cannabis use in patients with chronic musculoskeletal pain.了解慢性肌肉骨骼疼痛患者使用大麻的流行病学情况及感知疗效。
J Cannabis Res. 2024 Jul 3;6(1):28. doi: 10.1186/s42238-024-00231-1.
9
Awareness of medical cannabis regulations among UK police officers - a cross-sectional study.英国警察对医用大麻法规的认知-一项横断面研究。
Med Leg J. 2024 Jun;92(2):99-102. doi: 10.1177/00258172241237650. Epub 2024 May 17.
10
Potential role of cannabis in ameliorating observed racialized disparities in cancer pain management.大麻在改善癌症疼痛管理中观察到的种族差异方面的潜在作用。
J Natl Cancer Inst. 2024 Jul 1;116(7):1019-1025. doi: 10.1093/jnci/djae058.
本文引用的文献
1
Stigma predicts residential treatment length for substance use disorder.耻辱感预示着物质使用障碍的住院治疗时长。
Am J Drug Alcohol Abuse. 2014 May;40(3):206-12. doi: 10.3109/00952990.2014.901337.
2
Changes in smoking-related norms in bars resulting from California's Smoke-Free Workplace Act.加利福尼亚州《无烟工作场所法案》导致酒吧内与吸烟相关规范的变化。
J Drug Educ. 2012;42(3):315-26. doi: 10.2190/DE.42.3.d.
3
Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review.卫生专业人员对药物使用障碍患者的污名化及其对医疗服务提供的影响：系统评价。
Drug Alcohol Depend. 2013 Jul 1;131(1-2):23-35. doi: 10.1016/j.drugalcdep.2013.02.018. Epub 2013 Mar 13.
4
Who are medical marijuana patients? Population characteristics from nine California assessment clinics.哪些是医用大麻患者？来自加利福尼亚州九个评估诊所的人口特征。
J Psychoactive Drugs. 2011 Apr-Jun;43(2):128-35. doi: 10.1080/02791072.2011.587700.
5
Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study.持续使用大麻与精神病症状的发生和持续存在的风险：10 年随访队列研究。
BMJ. 2011 Mar 1;342:d738. doi: 10.1136/bmj.d738.
6
Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis.精神疾病患者内化污名的相关性及其后果：系统评价和荟萃分析。
Soc Sci Med. 2010 Dec;71(12):2150-61. doi: 10.1016/j.socscimed.2010.09.030. Epub 2010 Oct 12.
7
Stigma and treatment for alcohol disorders in the United States.美国的酒精障碍污名化和治疗。
Am J Epidemiol. 2010 Dec 15;172(12):1364-72. doi: 10.1093/aje/kwq304. Epub 2010 Nov 2.
8
Adverse health effects of non-medical cannabis use.非医用大麻使用对健康的不良影响。
Lancet. 2009 Oct 17;374(9698):1383-91. doi: 10.1016/S0140-6736(09)61037-0.
9
Stigma, treatment beliefs, and substance abuse treatment use in historically disadvantaged communities.历史上处于弱势地位社区中的耻辱感、治疗观念与药物滥用治疗利用情况
Afr J Psychiatry (Johannesbg). 2009 Aug;12(3):218-22. doi: 10.4314/ajpsy.v12i3.48497.
10
Obesity, stigma and public health planning.肥胖、污名化与公共卫生规划。
Health Promot Int. 2009 Mar;24(1):88-93. doi: 10.1093/heapro/dan041. Epub 2009 Jan 8.
Zotero 插件